Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

As we cope with pandemic, innovators can thrive

    Home News As we cope with pandemic, innovators can thrive
    NextPrevious

    As we cope with pandemic, innovators can thrive

    By sarah | News | 0 comment | 5 April, 2020 | 0

    By Scott Meacham

    The COVID-19 medical and economic crisis is relentless. Every day more people, locations and institutions are impacted. Scientists and other experts are appropriately realistic. Matters are likely to worsen, at least near-term, before we flatten the curve of infection.

    Our hearts go out to the sick and their families. We send everlasting gratitude to the heroes of this situation wherever they are—the medical professionals, first responders, volunteers, and workers in critical industries who are selflessly putting the good of the whole ahead of their own self-interest.

    For these heroes, it’s a brutal, all-consuming battle on the front lines of this crisis. While they fight for swabs and masks and people’s lives, there’s a parallel battle going on. Powerful forces — compassion, collaboration, and ingenuity—are at work to lessen the burden of those who are suffering and to prevent a crisis like this from happening again, at least in the same way.

    In labs and hospitals all over the world, researchers and scientists are working 24/7 to create faster, more predictive medical tests, preventions, and cures. There are companies that are creating entirely new processes to ship and deliver goods to a world that is far less mobile than before.

    Whole industries are changing before our eyes. Physicians and insurers who may have been reluctant before are embracing the touch and efficiency of telemedicine. Distillers are making hand sanitizer. Supply chains are being reworked. Entrepreneurs are applying machine learning and the Internet of Things (IoT) to solve crushing problems that didn’t exist 90 days ago.

    Inertia — not lack of capital, not a shortage of talent, not regulation — is the biggest enemy of entrepreneurship and innovation. In the throes of a crisis like this, any appetite for inertia is wiped out. A compelling urge to find and fix is upon all of us — and that means opportunity, in the best sense of the word.

    Consider this example. James Dyson, inventor of the world’s first bagless vacuum cleaner, leads a billion dollar self-made global technology enterprise. In the last three weeks, Dyson’s company has invented a brand new ventilator to meet the specific needs of COVID-19 patients. The plan is to produce 15,000 of these ventilators by April.

    Will this ventilator do the job? Will its manufacture be easy and quick enough to save lives now? Who knows? But it’s a remarkable effort led by a bold and proven inventor who believes that he and his company can save lives in the next 30 days.

    No one knows where the bottom of the COVID-19 crisis is, nor how deep and wide this pandemic will become before we start to climb toward a new normalcy. We do know, however, that adversity makes us stronger. In times like these, ordinary people reach out and accomplish amazing things.

    Initially, this pandemic may have a chilling effect on startup activity in general. But new ideas will surface. Entrepreneurs early in their careers (like Dyson was 20-plus years and 5,127 vacuum prototypes ago) will come to the front with ideas that markets, customers and investors will consider.

    Pandemics produce extreme change. However, the spirit of problem-solving and entrepreneurship is contagious, too.

    Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. Contact Meacham at i2E_Comments@i2E.org.

    COVID-19, innovators, pandemic, Scott Meacham

    Related Post

    • Linear Health Sciences Announces U.S. FDA Clearance and Health Canada Approval of its Orchid Safety Release Valve (SRV)

      By sarah | Comments are Closed

      Device Intended to Reduce Risk of IV Catheter Failure and Replacement in Hospitals; Sister Product Orchid SRV-Type D for Drainage to Launch Simultaneously OKLAHOMA CITY, Okla. – May 17, 2022 – Medical device company LinearRead more

    • Student teams from OSU, TU and East Central claim Love’s Cup top awards

      By sarah | Comments are Closed

      May 3, 2022 Contact: Sarah Seagraves, Senior VP for Marketing (405) 813-2403 or email sseagraves@i2E.org Teams led by student innovators from Oklahoma State University, the University of Tulsa and East Central University claimed first placeRead more

    • A final column and a thank you for reading

      By sarah | Comments are Closed

      Thank you for reading this column for nearly a decade By Scott Meacham This is my final column for The Oklahoman. As CEO of i2E, I have had the wonderful opportunity since January 2013 to write thisRead more

    • A significant impact on new ventures? That’s i2E’s e3 program

      By sarah | Comments are Closed

      Accelerators like i2E’s e3 can have a significant impact on new ventures By Scott Meacham When the team from Zen Health Technologies formally introduces their company, they describe a business that uses immersive technologies for personalRead more

    • Autigen Announces Collaboration with Boehringer Ingelheim

      By sarah | 0 comment

      Novel Treatments for Hearing Loss Collaboration and licensing agreement to advance novel therapies for sensorineural hearing loss (SNHL), where there are currently no approved pharmacological therapies. OKLAHOMA CITY–(BUSINESS WIRE)– Autigen, a biotechnology portfolio company of theRead more

    Leave a Comment

    You must be logged in to post a comment.

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Media
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    100 S. Cincinnati Ave – 5th Floor, Suite 514
    Tulsa, OK 74103
    PHONE 918/582-5592
    Copyright 2022 i2E, Inc. | All Rights Reserved
    • About
    • Entrepreneurship
      • Venture Advisory Services
      • Love’s Entrepreneur’s Cup
      • ACT Tulsa
    • e3
    • Concept Fund
    • Portfolio
    • iMCI
    • ACT Tulsa
    • Contact
    i2E